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Changing Lives Through Research On the job
Innovative Therapies for
Pancreatic-Related Cancers
ancreatic cancer patients come to
Thomas Jefferson University Hospital
because of the reputation, skill, and track
records of its surgical staff, who perform a
high volume of surgeries. However, this
patient-centric approach to care is supported
by an impressive research capability that also
has significant impact on both the prevention
and recovery of pancreatic-related diseases.
Two world-class Jefferson researchers,
Hwyda Arafat, MD, PhD, and Jonathan Brody,
PhD, are making tremendous inroads toward
understanding the science and genesis of
pancreatic-related cancers. Their goal is to
manage or halt the progress of disease
through innovative and diverse therapies.
Dr. Arafat, Assistant Professor of Surgery,
has a PhD in cell biology and immunology. A
native of Egypt, she is currently investigating
pancreatic cancer as it pertains to the renin-
angiotensis system involved in hypertension.
She is also interested in the use of anti-
hypertension medications already on the
market to help treat pancreatic cancer. “I
have the patient on my mind everyday,”
she says. “It is my motivation, my hope that 
our research can help to make the 
disease manageable.”
In 2005, when Dr. Arafat began a
multidisciplinary approach in the lab that
expanded her work on diabetes, she began to
see correlations between patients who
received hypertension medications and a
decrease in cancer occurrences. “Clinical
trials are just a year away that will help us
understand whether the hypertension
therapies work, as well as the science behind
them,” explains Dr. Arafat.
Since joining the Jefferson faculty as
Assistant Professor in 2006, Dr. Brody has
concentrated on the complex molecular
genetics of pancreatic cancer. After earning
a PhD from the Johns Hopkins School of
Medicine, he completed post-doctoral
training in oncology with Scott E. Kern, MD,
who is world-renowned for his work in the
genetics of pancreatic cancer. Together they
revolutionized a basic molecular biology
technique (now patented) called DNA
electrophoresis, making it possible to see genetic
results five times faster with cleaner results.
A patient's tumor is collected during surgery
and then studied in the lab to understand its
specific genetics. Dr. Brody seeks to use this
information to develop anti-cancer therapies
through medication that will be suited to the
individual patient.
“By studying a tumor's genesis, we can
begin to understand the series of events that
led up to making a cell cancerous,” he says.
“We will then have isolated the molecular
defects-what went wrong-and can find a
better, more targeted, and sophisticated
approach for drug therapies.” Dr. Brody
explained that, just as we now know which
antibiotics work best for specific bacterial
strains, “we are striving to do the same for
pancreatic cancers, and we are already seeing
some very positive results.”
Doctors Arafat and Brody are at the
forefront of research in the field today. Dr.
Arafat was one of the Jefferson physicians to
represent Jefferson at the distinguished 2006
Southern Surgical Association Meeting in
Florida last November, where she presented
some of her recent findings. It is their goal
to leverage this work in the lab to ensure 
that patients survive pancreatic cancer in
increasing numbers and go on to live long
and healthy lives.
Donna Guinto, C-TAGME
Certified Training Administrator 
of Graduate Medical Education
Programs
Donna Guinto is a 22-year employee 
of Jefferson who has worked as the
Coordinator of the Surgical Residency
Program since 1994. She manages 
the administrative and supervisory
activities of the 51-resident program.
How do you prepare for selecting 
next year's residents?
In September, I begin downloading
applications. I do the preliminary
screening with the attendings doing 
the final review. This year we received
close to 1100 applications. It's a 
highly competitive process, with only 
six slots available each year.
What qualities do you seek in 
an applicant?
In addition to academic achievement,
preparedness, and communications skills,
we select candidates based on qualities
such as motivation, honesty, and integrity.
We look for team players — people
whose determination is fueled 
by a personal commitment to helping
others — patients and colleagues alike.
How do residents benefit from
Jefferson's rich academic tradition?
Jefferson was the second hospital in 
the U.S. to be directly associated with 
a medical school — a real pioneer in
combining patient care with formal
education. In the mid-1850s, the
department prospered under the
leadership of Samuel D. Gross, MD,
known then as the “Emperor of
American Surgery.” Our faculty carry
on his legacy of surgical innovation 
and passion for clinical education.
What are some of skills that your
job requires?
Multitasking – I manage the logistics 
of the program such as residents’
work hours and schedules and
monitor accreditation, board, and
institutional requirements. I document
the evaluation processes and counsel
residents in solving problems in their
personal and professional lives. It's 
a big job, but it comes with great
satisfaction, too.
Jonathan Brody, PhD and Hwyda Arafat, MD, PhD, conduct research that will lead to new
pancreatic cancer treatment options.
For an appointment with a Jefferson Surgeon, call 1-800-JEFF-NOW
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“Clinical trials are just a
year away that will help
us understand whether
the hypertension therapies
work, as well as the
science behind them.”
Donna Guinto in front of “The Board” —
hundreds of photographs documenting
the lives of past and present residents.
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